Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03901378
Title Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ochsner Health System

gastrointestinal neuroendocrine tumor

large cell neuroendocrine carcinoma

pancreatic endocrine carcinoma


Carboplatin + Etoposide + Pembrolizumab


Cisplatin + Etoposide + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Ochsner Clinic Foundation Kenner Louisiana 70065 United States Details
Ochsner Clinic Foundation New Orleans Louisiana 70121 United States Details
*Shaded cells indicate that there was no data available from for the field